Furthermore, since ATRA binds to PPARδ/β receptors with high affinity [31], targets of PPARδ/β signaling also would be dysregulated, further contributing to OS elevation, neuroinflammation, Aβ plaque formation, and phosphorylated tau, which together accelerate AD onset and progression [51]. Here, MAPT is linked to Alzheimer disease.